NCT01974440 2025-05-25SELENEJanssen Research & Development, LLCPhase 3 Completed403 enrolled 23 charts
NCT04745832 2024-11-04Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)MEI Pharma, Inc.Phase 3 Terminated82 enrolled 11 charts
NCT05934097 2023-07-06FT596 in Combination With R-CHOP in Subjects With B-Cell LymphomaFate TherapeuticsPhase 1 Withdrawn